{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:26:06Z","timestamp":1793834766603,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY24H160018"],"award-info":[{"award-number":["LY24H160018"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY22H280015"],"award-info":[{"award-number":["LY22H280015"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Administration Bureau of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2025ZR083"],"award-info":[{"award-number":["2025ZR083"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017599","name":"Science and Technology Program of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274144"],"award-info":[{"award-number":["82274144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.intimp.2026.116317","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:00:12Z","timestamp":1770426012000},"page":"116317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["MD2 suppresses anaplastic thyroid Cancer progression by reprogramming macrophages via USP15-mediated FHL1 Deubiquitination"],"prefix":"10.1016","volume":"173","author":[{"given":"Qilu","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.116317_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12020-020-02207-6","article-title":"Thyroid cancer: incidence and mortality trends in China, 2005-2015","volume":"68","author":"Wang","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.intimp.2026.116317_bb0010","article-title":"Thyroid Cancer: epidemiology, classification, risk factors, diagnostic and prognostic markers, and current treatment strategies","volume":"26, (11)","author":"Forma","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116317_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12022-021-09665-2","article-title":"Molecular pathology of poorly differentiated and anaplastic thyroid Cancer: what do pathologists need to know?","volume":"32","author":"Volante","year":"2021","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.intimp.2026.116317_bb0020","article-title":"Anaplastic thyroid cancer: an update","volume":"37, (1)","author":"Rao","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.intimp.2026.116317_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188928","article-title":"Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities","volume":"1878","author":"Zhang","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.116317_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12032-020-1345-2","article-title":"Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer","volume":"37, (3)","author":"Gentile","year":"2020","journal-title":"Med. Oncol."},{"key":"10.1016\/j.intimp.2026.116317_bb0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13046-022-02272-x","article-title":"Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies","volume":"41, (1)","author":"Kumari","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116317_bb0040","article-title":"Shaping polarization of tumor-associated macrophages in Cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116317_bb0045","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10238-022-00888-z","article-title":"Role of chemokines in the crosstalk between tumor and tumor-associated macrophages","volume":"23","author":"Qin","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2026.116317_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202506925","article-title":"Spatial Transcriptomics Reveals Transcriptomic and Immune Microenvironment Reprogramming during Thyroid Carcinoma Dedifferentiation","author":"Ning","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.intimp.2026.116317_bb0055","article-title":"Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma","volume":"6, (7)","author":"Caillou","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.intimp.2026.116317_bb0060","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1158\/1541-7786.MCR-23-0144","article-title":"Telomerase upregulation induces progression of mouse BrafV600E-driven thyroid cancers and triggers Nontelomeric effects","volume":"21","author":"Landa","year":"2023","journal-title":"Molecular cancer research\u202f: MCR"},{"key":"10.1016\/j.intimp.2026.116317_bb0065","article-title":"Genetic and pharmacological targeting of CSF-1\/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression","volume":"8, (1)","author":"Ryder","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2026.116317_bb0070","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7150\/thno.51777","article-title":"Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2026.116317_bb0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.actbio.2023.02.006","article-title":"Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy","volume":"160","author":"Cao","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.intimp.2026.116317_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112406","article-title":"Tumor-associated macrophages derived exosomes; from pathogenesis to therapeutic opportunities","volume":"136","author":"Hadad","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116317_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116317_bb0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6, (1)","author":"Xiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2026.116317_bb0095","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.7150\/thno.93473","article-title":"The CEBPB(+) glioblastoma subcluster specifically drives the formation of M2 tumor-associated macrophages to promote malignancy growth","volume":"14","author":"Yang","year":"2024","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.intimp.2026.116317_bb0100","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.cmet.2024.10.002","article-title":"Hexokinase 2 senses fructose in tumor-associated macrophages to promote colorectal cancer growth","volume":"36","author":"Yan","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.116317_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.995791","article-title":"Selective targeting of MD2 attenuates intestinal inflammation and prevents neonatal necrotizing enterocolitis by suppressing TLR4 signaling","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116317_bb0110","doi-asserted-by":"crossref","first-page":"13997","DOI":"10.1038\/ncomms13997","article-title":"Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116317_bb0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jnutbio.2019.04.003","article-title":"MD2 blockade prevents oxLDL-induced renal epithelial cell injury and protects against high-fat-diet-induced kidney dysfunction","volume":"70","author":"Xu","year":"2019","journal-title":"J. Nutr. Biochem."},{"issue":"8","key":"10.1016\/j.intimp.2026.116317_bb0120","first-page":"4001","article-title":"Higher intra-tumoral expression of pro-coagulation genes is a predictor of angiogenesis, epithelial mesenchymal transition and worse patient survival in gastric cancer","volume":"12","author":"Oshi","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116317_bb0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12929-022-00888-x","article-title":"Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-\u03baB and TGF-\u03b22 signaling","volume":"29, (1)","author":"Lin","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.116317_bb0130","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/1878-0261.12967","article-title":"SENP3 loss promotes M2 macrophage polarization and breast cancer progression","volume":"16","author":"Xiao","year":"2022","journal-title":"Mol. Oncol."},{"issue":"20","key":"10.1016\/j.intimp.2026.116317_bb0135","doi-asserted-by":"crossref","first-page":"9332","DOI":"10.7150\/thno.47137","article-title":"USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung Cancer","volume":"10","author":"Dai","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2026.116317_bb0140","article-title":"EZH2 inhibitors suppress colorectal Cancer by regulating macrophage polarization in the tumor microenvironment","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.intimp.2026.116317_bb0145","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.3390\/cancers14194687","article-title":"Dauguet, N, BRAF(V600E) Expression in Thyrocytes Causes Recruitment of Immunosuppressive STABILIN-1 Macrophages","volume":"14","author":"Spourquet","year":"2022","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.intimp.2026.116317_bb0150","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1111\/j.1582-4934.2010.01176.x","article-title":"Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues","volume":"14","author":"Shathasivam","year":"2010","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116317_bb0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1139\/bcb-2021-0507","article-title":"Targeting FHL1 impairs cell proliferation and differentiation of acute myeloid leukemia cells","volume":"100","author":"Liu","year":"2022","journal-title":"Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116317_bb0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.20892\/j.issn.2095-3941.2019.0420","article-title":"Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression","volume":"17","author":"Wei","year":"2020","journal-title":"Cancer Biol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.116317_bb0165","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s10565-022-09695-4","article-title":"Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1\/FHL1-mediated cell-cycle-checkpoint protein activity","volume":"39","author":"Luo","year":"2022","journal-title":"Cell Biol. Toxicol."},{"issue":"28","key":"10.1016\/j.intimp.2026.116317_bb0170","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1073\/pnas.1302676110","article-title":"STAT3 promotes motor neuron differentiation by collaborating with motor neuron-specific LIM complex","volume":"110","author":"Lee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.intimp.2026.116317_bb0175","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1091\/mbc.e04-08-0664","article-title":"The LIM\/homeodomain protein Islet1 recruits Janus tyrosine kinases and signal transducer and activator of transcription 3 and stimulates their activities","volume":"16","author":"Hao","year":"2005","journal-title":"Mol. Biol. Cell"},{"issue":"8","key":"10.1016\/j.intimp.2026.116317_bb0180","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.7150\/ijbs.70289","article-title":"Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.116317_bb0185","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/pr.119.018440","article-title":"Targeting Janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and Cancer: rationale, Progress, and caution","volume":"72","author":"Bharadwaj","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2026.116317_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/molecules27196515","article-title":"Discovery of E3 ligase ligands for target protein degradation","volume":"27","author":"Lee","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.intimp.2026.116317_bb0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbrc.2011.01.012","article-title":"Transgenic overexpression of USP15 in the heart induces cardiac remodeling in mice","volume":"405","author":"Isumi","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:12:42Z","timestamp":1777619562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692600161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":39,"alternative-id":["S156757692600161X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116317","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MD2 suppresses anaplastic thyroid Cancer progression by reprogramming macrophages via USP15-mediated FHL1 Deubiquitination","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116317"}}